Atrás
Precio Innovent Biologics, Inc. (01801.HK)
Gráfico del Precio de Acciones 01801.HK
INNOVENT BIO (01801.HK)
Innovent Biologics, Inc.
HK$82.8
-0.83%
$-0.7
Mercado cerrado: Jan 21, 16:00:00 HKT
Estadísticas clave
Cierre Anterior
$83.2
Precio de apertura
$83.5
Rango del día
$81.55 - $83.75
Rango de 52 semanas
$28.65 - $109.1
Volumen
9.1M
Volumen promedio
14.6M
EPS (TTM)
0.75
Rendimiento de dividendos
--
Cap. de mercado
$142.4B
¿Qué es INNOVENT BIO?
Innovent Biologics, Inc. is a biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases. The company is headquartered in Suzhou, Jiangsu and currently employs 6,190 full-time employees. The company went IPO on 2018-10-31. The pipeline covering monoclonal antibodies, multi-specific antibodies, immuno-cytokine, antibody-drug conjugates (ADCs), cell therapy and small molecules. The Company’s main products include TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), Pemazyre (pemigatinib) and others. The firm mainly conducts its businesses within domestic and overseas markets.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved
